Identifying environmental risk factors for post-acute sequelae of SARS-CoV-2 infection: An EHR-based cohort study from the recover program - PubMed (original) (raw)
doi: 10.1016/j.envadv.2023.100352. Epub 2023 Feb 8.
Hui Hu 2, Vasilios Fokaidis 1, Colby Lewis V 1, Jie Xu 3, Chengxi Zang 1, Zhenxing Xu 1, Fei Wang 1, Michael Koropsak 1, Jiang Bian 3, Jaclyn Hall 3, Russell L Rothman 4, Elizabeth A Shenkman 3, Wei-Qi Wei 5, Mark G Weiner 1, Thomas W Carton 6, Rainu Kaushal 1
Affiliations
- PMID: 36785842
- PMCID: PMC9907788
- DOI: 10.1016/j.envadv.2023.100352
Identifying environmental risk factors for post-acute sequelae of SARS-CoV-2 infection: An EHR-based cohort study from the recover program
Yongkang Zhang et al. Environ Adv. 2023 Apr.
Abstract
Post-acute sequelae of SARS-CoV-2 infection (PASC) affects a wide range of organ systems among a large proportion of patients with SARS-CoV-2 infection. Although studies have identified a broad set of patient-level risk factors for PASC, little is known about the association between "exposome"-the totality of environmental exposures and the risk of PASC. Using electronic health data of patients with COVID-19 from two large clinical research networks in New York City and Florida, we identified environmental risk factors for 23 PASC symptoms and conditions from nearly 200 exposome factors. The three domains of exposome include natural environment, built environment, and social environment. We conducted a two-phase environment-wide association study. In Phase 1, we ran a mixed effects logistic regression with 5-digit ZIP Code tabulation area (ZCTA5) random intercepts for each PASC outcome and each exposome factor, adjusting for a comprehensive set of patient-level confounders. In Phase 2, we ran a mixed effects logistic regression for each PASC outcome including all significant (false positive discovery adjusted p-value < 0.05) exposome characteristics identified from Phase I and adjusting for confounders. We identified air toxicants (e.g., methyl methacrylate), particulate matter (PM2.5) compositions (e.g., ammonium), neighborhood deprivation, and built environment (e.g., food access) that were associated with increased risk of PASC conditions related to nervous, blood, circulatory, endocrine, and other organ systems. Specific environmental risk factors for each PASC condition and symptom were different across the New York City area and Florida. Future research is warranted to extend the analyses to other regions and examine more granular exposome characteristics to inform public health efforts to help patients recover from SARS-CoV-2 infection.
Keywords: Air pollution; Built environment; Exposome; Long-COVID; Neighborhood deprivation; SARS-CoV-2 infection.
© 2023 The Author(s).
Conflict of interest statement
We declare that we have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
Graphical abstract
Fig. 1
Significant Exposome Factors Associated with PASC Groups in Phase 1 Analysis Using INSIGHT Sample.
Fig. 2
Significant Exposome Factors Associated with PASC Groups in Phase 1 Analysis Using OneFlorida+ Sample.
Fig. 3
Environmental Risk Factors for PASC Conditions by Organ System.
Update of
- Identifying Contextual and Spatial Risk Factors for Post-Acute Sequelae of SARS-CoV-2 Infection: An EHR-based Cohort Study from the RECOVER Program.
Zhang Y, Hu H, Fokaidis V, Lewis C, Xu J, Zang C, Xu Z, Wang F, Koropsak M, Bian J, Hall J, Rothman RL, Shenkman EA, Wei WQ, Weiner MG, Carton TW, Kaushal R. Zhang Y, et al. medRxiv [Preprint]. 2022 Oct 13:2022.10.13.22281010. doi: 10.1101/2022.10.13.22281010. medRxiv. 2022. PMID: 36263067 Free PMC article. Updated. Preprint.
Similar articles
- Identifying Contextual and Spatial Risk Factors for Post-Acute Sequelae of SARS-CoV-2 Infection: An EHR-based Cohort Study from the RECOVER Program.
Zhang Y, Hu H, Fokaidis V, Lewis C, Xu J, Zang C, Xu Z, Wang F, Koropsak M, Bian J, Hall J, Rothman RL, Shenkman EA, Wei WQ, Weiner MG, Carton TW, Kaushal R. Zhang Y, et al. medRxiv [Preprint]. 2022 Oct 13:2022.10.13.22281010. doi: 10.1101/2022.10.13.22281010. medRxiv. 2022. PMID: 36263067 Free PMC article. Updated. Preprint. - Clinical features and burden of post-acute sequelae of SARS-CoV-2 infection in children and adolescents: an exploratory EHR-based cohort study from the RECOVER program.
Rao S, Lee GM, Razzaghi H, Lorman V, Mejias A, Pajor NM, Thacker D, Webb R, Dickinson K, Bailey LC, Jhaveri R, Christakis DA, Bennett TD, Chen Y, Forrest CB. Rao S, et al. medRxiv [Preprint]. 2022 May 25:2022.05.24.22275544. doi: 10.1101/2022.05.24.22275544. medRxiv. 2022. PMID: 35665016 Free PMC article. Updated. Preprint. - Risk Factors and Predictive Modeling for Post-Acute Sequelae of SARS-CoV-2 Infection: Findings from EHR Cohorts of the RECOVER Initiative.
Zang C, Hou Y, Schenck E, Xu Z, Zhang Y, Xu J, Bian J, Morozyuk D, Khullar D, Nordvig A, Shenkman E, Rothman R, Block J, Lyman K, Zhang Y, Varma J, Weiner M, Carton T, Wang F, Kaushal R; RECOVER Consortium. Zang C, et al. Res Sq [Preprint]. 2023 Mar 8:rs.3.rs-2592194. doi: 10.21203/rs.3.rs-2592194/v1. Res Sq. 2023. PMID: 36945608 Free PMC article. Updated. Preprint. - Neurological post-acute sequelae of SARS-CoV-2 infection.
Takao M, Ohira M. Takao M, et al. Psychiatry Clin Neurosci. 2023 Feb;77(2):72-83. doi: 10.1111/pcn.13481. Epub 2022 Oct 17. Psychiatry Clin Neurosci. 2023. PMID: 36148558 Free PMC article. Review. - The Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 infection.
Moghimi N, Di Napoli M, Biller J, Siegler JE, Shekhar R, McCullough LD, Harkins MS, Hong E, Alaouieh DA, Mansueto G, Divani AA. Moghimi N, et al. Curr Neurol Neurosci Rep. 2021 Jun 28;21(9):44. doi: 10.1007/s11910-021-01130-1. Curr Neurol Neurosci Rep. 2021. PMID: 34181102 Free PMC article. Review.
Cited by
- A roadmap to advance exposomics through federation of data.
Schmitt CP, Stingone JA, Rajasekar A, Cui Y, Du X, Duncan C, Heacock M, Hu H, Gonzalez JR, Juarez PD, Smirnov AI. Schmitt CP, et al. Exposome. 2023;3(1):osad010. doi: 10.1093/exposome/osad010. Epub 2023 Nov 14. Exposome. 2023. PMID: 39267798 Free PMC article. - Japan's State of Emergency: How Political Decisions Affected Post-COVID-19 Syndrome.
Kaneda Y. Kaneda Y. JMA J. 2024 Jul 16;7(3):453-454. doi: 10.31662/jmaj.2023-0147. Epub 2024 Jun 10. JMA J. 2024. PMID: 39114604 Free PMC article. No abstract available. - Pathogenesis Underlying Neurological Manifestations of Long COVID Syndrome and Potential Therapeutics.
Leng A, Shah M, Ahmad SA, Premraj L, Wildi K, Li Bassi G, Pardo CA, Choi A, Cho SM. Leng A, et al. Cells. 2023 Mar 6;12(5):816. doi: 10.3390/cells12050816. Cells. 2023. PMID: 36899952 Free PMC article. Review.
References
- Bliddal S., Banasik K., Pedersen O.B., Nissen J., Cantwell L., Schwinn M., Tulstrup M., Westergaard D., Ullum H., Brunak S., Tommerup N., Feenstra B., Geller F., Ostrowski S.R., Gronbaek K., Nielsen C.H., Nielsen S.D., Feldt-Rasmussen U. Acute and persistent symptoms in non-hospitalized PCR-confirmed COVID-19 patients. Sci. Rep. 2021;11(1):13153. doi: 10.1038/s41598-021-92045-x. - DOI - PMC - PubMed
- Blomberg B., Mohn K.G., Brokstad K.A., Zhou F., Linchausen D.W., Hansen B.A., Lartey S., Onyango T.B., Kuwelker K., Saevik M., Bartsch H., Tondel C., Kittang B.R., Bergen C.-R.G., Cox R.J., Langeland N. Long COVID in a prospective cohort of home-isolated patients. Nat. Med. 2021;27(9):1607–1613. doi: 10.1038/s41591-021-01433-3. - DOI - PMC - PubMed
- Bull-Otterson L., Baca S., Saydah S., Boehmer T.K., Adjei S., Gray S., Harris A.M. Post–COVID Conditions Among Adult COVID-19 Survivors Aged 18–64 and≥ 65 Years—United States, March 2020–November 2021. Morb. Mortal. Wkly. Rep. 2022;71(21):713.
LinkOut - more resources
Full Text Sources
Miscellaneous